tiprankstipranks
Trending News
More News >

Eyenovia Launches Co-Branded Hyperliquid Validator with Kinetiq

Story Highlights
  • Eyenovia announced a co-branded Hyperliquid validator with Kinetiq on June 25, 2025.
  • The validator enhances network stability and positions Eyenovia as a bridge between public markets and the onchain economy.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Eyenovia Launches Co-Branded Hyperliquid Validator with Kinetiq

Confident Investing Starts Here:

An announcement from Eyenovia ( (EYEN) ) is now available.

On June 25, 2025, Eyenovia announced a co-branded Hyperliquid validator with Kinetiq, marking a significant step in its onchain engagement strategy. This initiative aligns with Eyenovia’s acquisition of HYPE tokens to enhance network stability and security, potentially benefiting investors through strategic participation and partnerships. The validator reflects Eyenovia’s dual approach of bridging public markets with the onchain economy, positioning itself uniquely in the industry.

The most recent analyst rating on (EYEN) stock is a Buy with a $560.00 price target. To see the full list of analyst forecasts on Eyenovia stock, see the EYEN Stock Forecast page.

Spark’s Take on EYEN Stock

According to Spark, TipRanks’ AI Analyst, EYEN is a Underperform.

Eyenovia’s stock is heavily weighed down by poor financial performance, including significant operational losses and a weak balance sheet. While there is revenue growth, the negative equity and insufficient cash flow generation are critical risks. Technical indicators also point to a bearish trend, and the valuation metrics are unappealing due to a negative P/E ratio and absence of dividends. These factors result in a low overall score.

To see Spark’s full report on EYEN stock, click here.

More about Eyenovia

Eyenovia, Inc. is a pioneering digital ophthalmic technology company and the first publicly listed U.S. company to build a strategic treasury of Hyperliquid’s native token, HYPE. The company focuses on revolutionizing topical eye treatment and providing shareholders with exposure to the Hyperliquid ecosystem, a rapidly growing blockchain. Eyenovia is also developing the Optejet User Filled Device for ophthalmic liquids, enhancing treatment compliance and outcomes.

Average Trading Volume: 4,185,808

Technical Sentiment Signal: Sell

Current Market Cap: $27.53M

For an in-depth examination of EYEN stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1